Hosted on MSN7h
William Blair Initiates Coverage of Mersana Therapeutics (MRSN) with Outperform RecommendationFintel reports that on February 6, 2025, William Blair initiated coverage of Mersana Therapeutics (NasdaqGS:MRSN) with a ...
William Blair analyst Andy Hsieh last night initiated coverage of Mersana Therapeutics (MRSN) with an Outperform rating. The firm believes ...
William Blair initiated coverage on Mersana Therapeutics, Inc. (NASDAQ:MRSN) with an Outperform rating. The firm's analyst cited the company's potential in the antibody-drug conjugates (ADCs) market ...
Mersana Therapeutics, Inc. (MRSN) stock price is 0.61 and Mersana Therapeutics, Inc. (MRSN) 10-day simple moving average is 0.59. Mersana Therapeutics, Inc. (MRSN) stock price is 0.61 and Mersana ...
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Zoetis (ZTS – Research Report), Terns ...
Pre-Market: 5:08:48 a.m. EST Loading Chart for MRSN ...
ISELIN, N.J., Jan. 31, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United ...
After hours: February 3 at 6:54:22 PM EST Loading Chart for BTAI ...
After hours: 7:57:32 p.m. EST Loading Chart for CGTX ...
Sanofi S.A. Part Cert 0.02% €8.03M ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback